E-LIB Suche - Ergebnisse für: Balık Aydın, Berrin

1

Plerixafor in autologous stem cell transplantation: Does it..:

Serin, Istemi ; Sevindik, Omur Gokmen ; Balik Aydin, Berrin...
Transfusion and Apheresis Science. 62 (2023) 6 - p. 103809 , 2023

Link: https://doi.org/10.1016/..

2

Pegaspargase, venetoclax, and nelarabine: a successful brid..:

Yiğit Kaya, Süreyya ; Bektas, Sebnem ; Askin, Abdullah Emre...
Annals of Hematology. 102 (2023) 6 - p. 1599-1600 , 2023

Link: https://doi.org/10.1007/..

3

Clinical Characteristics and Outcomes of COVID-19 in Turkis..:

Civriz Bozdağ, Sinem ; Seval, Güldane Cengiz ; Yönal Hindilerden, İpek...
Turkish Journal of Hematology. 39 (2022) 1 - p. 43-54 , 2022

Link: https://doi.org/10.4274/..

4

Persistent Polyclonal B-cell Lymphocytosis with Binucleated..:

Balık Aydın, Berrin ; Mutlu, Yaşa Gül ; Sevindik, Ömür Gökmen
Turkish Journal of Hematology. , 2021

Link: https://doi.org/10.4274/..

5

Germline CEBPA Mutation as a Rare Cause of Chronic Neutrope..:

Askin, Abdullah Emre ; Bektas, Sebnem ; Serin, Istemi...
Indian Journal of Hematology and Blood Transfusion. , 2024

Link: https://doi.org/10.1007/..

6

POSTER: CT-151 A Rare Bleeding Diathesis With Subacute Sple..:

Aydın, Berrin Balık
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S234 , 2023

Link: https://doi.org/10.1016/..

7

CT-151 A Rare Bleeding Diathesis With Subacute Splenic Hema..:

Aydın, Berrin Balık
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S519-S520 , 2023

Link: https://doi.org/10.1016/..

8

CYTARABİNE-İNDUCED NEUROTOXİCİTY WELL-RESPONDİNG TO METHYL ..:

Aydin, Berrin Balik
Hematology, Transfusion and Cell Therapy. 45 (2023) - p. S31 , 2023

Link: https://doi.org/10.1016/..

9

Prognostic Factors and Intensive Care Outcome in Post-Trans..:

Mutlu, Yaşa Gül ; Aydin, Berrin Balik ; Erdogan, Cem...
Indian Journal of Hematology and Blood Transfusion. 39 (2022) 2 - p. 167-172 , 2022

Link: https://doi.org/10.1007/..

10

CD5 as a prognostic marker in patients with diffuse large B..:

Demirci, Ufuk ; Kırkızlar, Hakkı Onur ; Ümit, Elif G....
Journal of Hematopathology. 15 (2022) 4 - p. 203-213 , 2022

Link: https://doi.org/10.1007/..

11

First-line Usage of Daratumumab, Lenalidomide, Dexamethason..:

Sevindik, Omur Gokmen ; Mutlu, Yasa Gul ; Aydin, Berrin Balik.
HemaSphere. 6 (2022) 7 - p. e728 , 2022

Link: https://doi.org/10.1097/..

12

To rechallenge or not to rechallenge, that is the question?..:

Sevindik, Omur Gokmen ; Mergen, Mahmut ; Mergen, Sena...
Annals of Hematology. 101 (2022) 11 - p. 2545-2547 , 2022

Link: https://doi.org/10.1007/..

13

IBCL-386: Rituximab-Vemurafenib Combination for the Treatme..:

Sevindik, Ömür ; Gemici, Aliihsan ; Mutlu, Yasa Gul..
Clinical Lymphoma Myeloma and Leukemia. 20 (2020) - p. S286 , 2020

Link: https://doi.org/10.1016/..

14

Should core needle lymph node biopsy be a relevant alternat..:

Mutlu, Yaşa Gül ; Balık Aydın, Berrin ; Çakır, Aslı...
The Eurasian Journal of Medicine. , 2023

Link: https://hdl.handle.net/2..

15

Clinical outcomes and treatment patterns of primary central..:

Güven, Serkan ; Yavuz, Boran ; Erdoğan Yücel, Elçin...
Eurasian Journal of Medicine and Oncology. , 2023

Link: https://hdl.handle.net/2..